{Reference Type}: Journal Article
{Title}: Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease.
{Author}: Coco G;Buffon G;Taloni A;Giannaccare G;
{Journal}: Nanomaterials (Basel)
{Volume}: 14
{Issue}: 8
{Year}: 2024 Apr 12
{Factor}: 5.719
{DOI}: 10.3390/nano14080669
{Abstract}: Dry eye disease (DED) incidence is continuously growing, positioning it to become an emergent health issue over the next few years. Several topical treatments are commonly used to treat DED; however, reports indicate that only a minor proportion of drug bioavailability is achieved by the majority of eye drops available on the market. In this context, enhancing drug ability to overcome ocular barriers and prolonging its residence time on the ocular surface represent a new challenge in the field of ocular carrier systems. Therefore, research has focused on the development of multi-functional nanosystems, such as nanoemulsions, liposomes, dendrimers, hydrogels, and other nanosized carriers. These systems are designed to improve topical drug bioavailability and efficacy and, at the same time, require fewer daily administrations, with potentially reduced side effects. This review summarizes the different nanotechnologies developed, their role in DED, and the nanotechnology-based eyedrops currently approved for DED treatment.